Do I or Don’t I?
What does that positive hepatitis C antibody result really mean?
Major Med Mistake
Rick Nash: Missing a dose of Harvoni had no side effects. I can’t say the same for doubling up.
A Viral Diaspora
How hep C genotype 2 spread from Africa to the rest of the world.
The Marathoner’s Journey
Endurance athlete, Matt Starr endured through hepatitis C treatment. Can you?
Heads up Geno 2’s & 3’s
Feel left out by new hep C treatments? You still have plenty of options.
The Evidence is Crystal Clear
Lucinda K. Porter, on the importance of widespread screening and treatment for hep C.
Check out part 3 of Kim Bossley’s blog series on relationships and hepatitis C.
One Pill For All
If approved, Gilead’s newest hep C combo could be the first-ever pan-genotypic, all-oral cure.
Combo Pill, Combo Virus
For patients with both HIV and hep C, Gilead’s Harvoni is 98% effective.
Hey, doctors: What’s the best way to motivate people through HCV treatment?
BMS Loses Fast-Track Status
FDA will revoke “breakthrough” designation for new hep C drug, daclatasvir.
Daclatasvir + Sovaldi Cure 97%
High SVR rates were achieved for hepatitis C genotypes 1-4.
TURQUOISE Trial Success
AbbVie’s Viekira Pak plus ribavirin boasts 91% cures for HIV/HCV coinfected.
Getting into Quality Care
HCV researchers say getting referrals for specialists is the hardest part.
Denied Hep C Treatment?
Here’s how to fight back against insurance companies and Medicaid.
Get into Advocacy
Want to raise awareness about hep C? Click here for a list of online resources.
Your Online Hepatitis Community
Check out what everyone's talking about in the Hep Forums.
Inside Alcoholic Liver Disease
The onset and intensity of drinking-related liver problems could vary by race.
New safe injection shots help stop HIV and hepatitis by preventing a second use.
amfAR Speaks Up About HCV
The Foundation for AIDS Research criticizes the state of hep C drug pricing.
Partial Liver Transplants
With donated organs in such short supply, doctors are turning to a new alternative.
New Leadership For NASTAD
The organization’s executive director, Julie Schofield steps down after 22 years.
$50M Pledged For HCV Research
PCORI is asking both private/public-sector organizations to apply for grants.
Cultural Case Study
A look at hepatitis C transmission in West Africa.